Arlington Capital Management’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,529	Closed	-$1.22M	–	98
2024 Q1	$1.22M	Buy	9,529 +9	+0.1%	+$1.16K	1.02%	32
2023 Q4	$985K	Buy	+9,520	New	+$985K	0.9%	34